The Fertility Preservation Guidelines for Cancer Patients Undergoing Chemotherapy aim to help patients make informed decisions before treatment when facing potential fertility impairment due to chemotherapy. Chemotherapeutic agents can cause irreversible damage to ovarian or testicular function, making fertility preservation especially critical for young patients. The guidelines recommend that all reproductive-age cancer patients undergo a fertility risk assessment prior to initiating chemotherapy and receive individualized counseling from a multidisciplinary team, including oncologists and reproductive specialists. Options for women include oocyte cryopreservation, embryo cryopreservation, or ovarian tissue cryopreservation; men can preserve fertility through sperm banking. For prepubertal patients, cryopreservation of ovarian or testicular tissue is currently the only viable option. The guidelines also emphasize the importance of psychological support and ethical considerations to ensure patients fully understand success rates, costs, and potential risks. Timely referral to fertility centers and acting within the narrow window before chemotherapy begins are crucial for successful fertility preservation. These guidelines not only enhance patients’ quality of life but also reflect a patient-centered, holistic approach to cancer care.
肿瘤化疗患者生育力保存指南旨在帮助面临化疗可能影响生育能力的患者，在治疗前做出知情决策。化疗药物可能对卵巢或睾丸功能造成不可逆损伤，尤其对年轻患者而言，生育力保存至关重要。指南建议：所有育龄期肿瘤患者在开始化疗前应接受生育力风险评估，并由多学科团队（包括肿瘤科、生殖医学科等）提供个体化咨询。女性可选择卵子冷冻、胚胎冷冻或卵巢组织冷冻；男性则可通过精子冷冻保存生育力。对于青春期前患者，卵巢或睾丸组织冷冻是目前唯一可行方案。此外，指南强调心理支持与伦理考量的重要性，确保患者充分理解保存技术的成功率、费用及潜在风险。及时转诊至生殖中心、把握治疗窗口期，是成功保存生育力的关键。该指南不仅提升患者生活质量，也体现了以患者为中心的综合照护理念。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/1392.html